Overview

Non-Communicable Diseases (NCDs) are rapidly emerging as one of Africa’s most pressing health and development challenges. Chronic illnesses such as diabetes, cancer, cardiovascular disease, and mental health disorders now account for a growing share of mortality, disability, and healthcare expenditure.

At VIBRI, we collaborate with donors and partners to generate high-quality evidence that supports prevention, early diagnosis, and long-term care for NCDs. Strategic donor investment is essential to building resilient health systems capable of managing chronic disease and improving quality of life across communities.

Priority Therapuetic Areas

01

Sickle Cell Disease

Sickle cell disease places a lifelong burden on affected individuals and families. With donor support, VIBRI advances research into improved therapeutic options, comprehensive care models, and emerging innovations that enhance survival and quality of life.
02

Diabetes Mellitus

Diabetes prevalence is increasing rapidly, often remaining undiagnosed until complications arise. VIBRI’s research focuses on early detection, effective treatment strategies, and health system responses that reduce long-term complications and associated healthcare costs.
03

Cardiovascular Diseases

Hypertension, heart disease, and stroke are leading causes of premature death. Donor-supported studies at VIBRI inform prevention strategies, clinical guidelines, and scalable interventions that improve cardiovascular health outcomes.
04

Asthma and Chronic Respiratory Diseases

Respiratory conditions reduce productivity and quality of life. VIBRI investigates environmental, genetic, and clinical factors influencing disease progression to improve diagnosis, management, and treatment outcomes.
05

Mental Health

Mental health disorders remain underfunded and stigmatized despite their significant social and economic impact. VIBRI promotes evidence-based psychosocial interventions and integrated care models that expand access and improve patient outcomes.
06

Oncology (Cancer Research)

Cancer incidence is rising across Africa, often diagnosed at advanced stages. Our research emphasizes early detection, treatment pathways, and context-appropriate cancer care to improve survival and reduce inequities.
07

Maternal and Reproductive Health

Chronic and non-communicable conditions significantly affect maternal outcomes. VIBRI’s research strengthens evidence for safer pregnancies, healthier mothers, and improved long-term family wellbeing.
08

Endocrine Disorders

Hormonal and metabolic disorders require lifelong management. VIBRI advances research that improves diagnosis, treatment pathways, and integrated models of endocrine care.
01

Sickle Cell Disease

Sickle cell disease places a lifelong burden on affected individuals and families. With donor support, VIBRI advances research into improved therapeutic options, comprehensive care models, and emerging innovations that enhance survival and quality of life.
02

Diabetes Mellitus

Diabetes prevalence is increasing rapidly, often remaining undiagnosed until complications arise. VIBRI’s research focuses on early detection, effective treatment strategies, and health system responses that reduce long-term complications and associated healthcare costs.
03

Cardiovascular Diseases

Hypertension, heart disease, and stroke are leading causes of premature death. Donor-supported studies at VIBRI inform prevention strategies, clinical guidelines, and scalable interventions that improve cardiovascular health outcomes.
04

Asthma and Chronic Respiratory Diseases

Respiratory conditions reduce productivity and quality of life. VIBRI investigates environmental, genetic, and clinical factors influencing disease progression to improve diagnosis, management, and treatment outcomes.
05

Mental Health

Mental health disorders remain underfunded and stigmatized despite their significant social and economic impact. VIBRI promotes evidence-based psychosocial interventions and integrated care models that expand access and improve patient outcomes.
06

Oncology (Cancer Research)

Cancer incidence is rising across Africa, often diagnosed at advanced stages. Our research emphasizes early detection, treatment pathways, and context-appropriate cancer care to improve survival and reduce inequities.
07

Maternal and Reproductive Health

Chronic and non-communicable conditions significantly affect maternal outcomes. VIBRI’s research strengthens evidence for safer pregnancies, healthier mothers, and improved long-term family wellbeing.
08

Endocrine Disorders

Hormonal and metabolic disorders require lifelong management. VIBRI advances research that improves diagnosis, treatment pathways, and integrated models of endocrine care.

Our Research Model

  • Donor-funded clinical and observational studies

  • Health systems and outcomes research

  • Prevention and early diagnosis strategies

  • Long-term disease management models

  • Multidisciplinary and cross-sector collaboration

Impact for Donors

Investment in non-communicable disease research delivers long-term, sustainable value:

  • Reduced burden on overstretched health systems

  • Improved productivity and quality of life

  • Evidence-based policy and clinical decision-making

  • Stronger, more resilient healthcare systems

Partner With Us

Support VIBRI’s mission to address Africa’s growing chronic disease burden.